CareDx, Inc. (CDNA)
47.50
-1.11
(-2.28%)
USD |
NASDAQ |
Aug 24, 16:00
48.00
+0.50
(+1.05%)
Pre-Market: 08:43
CareDx Debt to Equity Ratio : 0.0452 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0452 |
| March 31, 2026 | 0.0781 |
| December 31, 2025 | 0.0864 |
| September 30, 2025 | 0.0888 |
| June 30, 2025 | 0.089 |
| March 31, 2025 | 0.0798 |
| December 31, 2024 | 0.075 |
| September 30, 2024 | 0.1097 |
| June 30, 2024 | 0.1188 |
| March 31, 2024 | 0.1286 |
| December 31, 2023 | 0.131 |
| September 30, 2023 | 0.0893 |
| June 30, 2023 | 0.0898 |
| March 31, 2023 | 0.0899 |
| December 31, 2022 | 0.0905 |
| September 30, 2022 | 0.0914 |
| June 30, 2022 | 0.043 |
| March 31, 2022 | 0.0446 |
| December 31, 2021 | 0.0458 |
| September 30, 2021 | 0.046 |
| June 30, 2021 | 0.0441 |
| March 31, 2021 | 0.0459 |
| December 31, 2020 | 0.0654 |
| September 30, 2020 | 0.069 |
| June 30, 2020 | 0.0726 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.1904 |
| December 31, 2019 | 0.0333 |
| September 30, 2019 | 0.0242 |
| June 30, 2019 | 0.026 |
| March 31, 2019 | 0.0237 |
| December 31, 2018 | 0.0044 |
| September 30, 2018 | 0.3128 |
| June 30, 2018 | 0.4762 |
| March 31, 2018 | 0.3125 |
| December 31, 2017 | -5.555 |
| September 30, 2017 | -116.45 |
| June 30, 2017 | 2.869 |
| March 31, 2017 | 2.218 |
| December 31, 2016 | 1.263 |
| September 30, 2016 | 0.7722 |
| June 30, 2016 | 0.9407 |
| March 31, 2016 | 0.7747 |
| December 31, 2015 | 0.5365 |
| September 30, 2015 | 0.4659 |
| June 30, 2015 | 0.4305 |
| March 31, 2015 | 0.3985 |
| December 31, 2014 | 0.278 |
| September 30, 2014 | 0.3121 |
| June 30, 2014 | -12.94 |
| March 31, 2014 | -0.9038 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Natera, Inc. | 0.1309 |
| Caris Life Sciences, Inc. | 0.7645 |
| Myriad Genetics, Inc. | 0.6927 |
| BioRestorative Therapies, Inc. | 0.0114 |
| Exagen, Inc. | 2.264 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 532.99M |
| Total Liabilities (Quarterly) | 107.39M |
| Shareholders Equity (Quarterly) | 425.60M |
| Current Ratio | 4.581 |
| Net Debt Paydown Yield | 0.15% |